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Abstract 
Background: Tumor response to immunotherapy is the consequence of a concerted crosstalk between cytokines 
and effector cells. Interferon gamma (IFNγ) is one of the common cytokines coordinating tumor immune response 
and the associated biological consequences. Although the role of IFNγ in the modulation of tumor immunity has 
been widely documented, the mechanisms regulating IFNγ-induced cell death, during the course of immune therapy, 
is not described in detail.
Results: IFNγ triggered apoptosis of CLS-354 and RPMI 2650 cells, enhanced the protein expression and activation of 
indoleamine 2,3-dioxygenase (IDO), and suppressed the basal expression of heme oxygenase-1(HO-1). Interestingly, 
IFNγ induced the loss of mitochondrial membrane potential (Δψm) and increased accumulation of reactive oxygen 
species (ROS). The cytokine also induced the activation of Janus kinase (JAK)/Signal Transducer and Activator of Tran-
scription (STAT)1, apoptosis signal-regulating kinase 1 (ASK1), p38, c-jun-N-terminal kinase (JNK) and NF-κB pathways 
and the transcription factors STAT1, interferon regulatory factor 1 (IRF1), AP-1, ATF-2, NF-κB and p53, and expression of 
Noxa protein. Furthermore, IFNγ was found to trigger endoplasmic reticulum (ER) stress as evidenced by the cleavage 
of caspase-4 and activation of protein kinase RNA-like endoplasmic reticulum kinase (PERK) and inositol-requiring-1α 
(IRE1α) pathways. Using specific inhibitors, we identified a potential role for IDO as apoptotic mediator in the regula-
tion of IFNγ-induced apoptosis of head and neck squamous cell carcinoma (HNSCC) cells via Noxa-mediated mito-
chondrial dysregulation and ER stress.
Conclusion: In addition to the elucidation of the role of IDO in the modulation of apoptosis, our study provides new 
insights into the molecular mechanisms of IFNγ-induced apoptosis of HNSCC cells during the course of immune 
therapy.
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Background
The tumor response to immunotherapy is the consequence 
of a concerted crosstalk between cytokines and effec-
tor cells [1]. Interferon gamma (IFNγ) is one of the cen-
tral cytokines that coordinates tumor immune responses 
and the associated biological consequences [2]. IFN-γ is 
a pleiotropic cytokine with multiple biological functions 
including immune cell activation [3, 4] and induction of 
the major histocompatibility complex (MHC) molecules 
both in normal and neoplastic cells [5, 6]. Besides its abil-
ity to trigger cell cycle arrest and apoptosis [7–10], IFN-γ 
shows anti-tumor activity in patients with advanced head 
and neck squamous cell carcinoma (HNSCC) [11] or non-
small-cell lung carcinoma (NSCLC) [12]. Although there is 
clinical data highlighting the reliability of IFN-γ as an anti-
tumor agent [10], the molecular action of IFN-γ as anti-
cancer agent has not been fully investigated. Because the 
current reported studies on the molecular action of IFN-γ 
in tumor cells are merely speculative, the aim of the pre-
sent study is to elucidate, in detail, the mechanisms which 
are responsible for the modulation of IFN-γ-induced 
effects on HNSCC cells.
IFNγ coordinates cellular functions via transcriptional 
regulation of innate and adaptive immune response-
associated genes such as indoleamine 2,3-dioxygenase 
(IDO) [13]. IDO is a rate limiting enzyme in the kynure-
nine enzymatic pathway that converts tryptophan (Trp) 
to N-formyl-kynurenine, which is the main source for 
the production of the cellular cofactor NAD+ [14]. While 
IDO has been found to be constitutively expressed in 
a limited number of human tissues [15], its induction 
and activation are tissue-specific and agent-dependent 
[15–17]. The induction of IDO by lipopolysaccharides 
(LPS), IFNγ, tumor necrosis factor alpha (TNF-α) and 
Fas receptor agonist (CH11) has been reported in differ-
ent cell types [15, 18–20]. An in vivo induction of IDO is 
associated with IFNγ-mediated inflammation that medi-
ates the innate immune response to intracellular patho-
gens and bacterial infection [21–24]. IDO is expressed 
in a wide array of human cancers [25], and the contri-
bution of IDO in the regulation of tumor cell death has 
been demonstrated in several studies [18, 19, 26, 27]. In 
accordance, it is expected that IDO contributes to the 
regulation of IFNγ-induced cell death.
Herein we demonstrate an essential role for IDO as an 
apoptotic mediator during the course of IFNγ-induced 
death of HNSCC cells via a mechanism mediated by 
IDO-dependent suppression of HO-1.
Methods
Assessment of cell survival
Human head and neck squamous cell carcinoma 
(HNSCC), CLS-354 CLS (Cell Lines Service GmbH, 
Germany) and SCC nasal septum, RPMI 2650 (ATCC® 
CCL-30™) obtained from the American Tissue Culture 
Collection (ATCC, Manassas, VA, USA) were seeded in 
96-microwell plates (1 × 104 cells/well), (Nunc, Waltham, 
MA, USA). The cells were challenged with IFNγ (1000 U/
ml) for the indicated time periods. The percentage of 
viable cells was then determined using the colorimetric 
MTT assay (Roche, Bâle, Switzerland) as described [28].
RNA interference
The knockdown of IDO gene was performed using 
siRNA, and negative control siRNA as described in the 
manufacturer’s protocol (Qiagen, Hilden; Germany). The 
transfection of the cell lines was performed using lipo-
fectamine 2000 (Invetrogen) as described [29].
Assay for intracellular IDO activity
The CLS-354 and RPMI 2650 cell lines (1  ×  104) were 
allowed to grow overnight in a 24-well plate. The cells 
were treated with IFNγ (1000 U/ml) for 48 h. The treated 
and control cells were harvested and washed three times 
in phosphate buffered saline (PBS). The cell pellet was 
snap frozen at −70 °C and next day was homogenized in 
0.5  ml PBS. Centrifugation was performed at 15,000×g 
for 10 min at 4 °C, then the supernatant was carefully col-
lected for measuring IDO activity as previously described 
[18]. Briefly, the cell extract was mixed with 100 μl reac-
tion buffer (100 mM potassium phosphate buffer pH 6.5, 
40 mM ascorbate, 20 μM methylene blue, 200 μg/ml cat-
alase, 800 μM l-tryptophan). This step followed by incu-
bation at 37  °C to activate the IDO enzyme to convert 
l-tryptophan to N-formyl-kynurenine. About 30  min 
later, the termination of the reaction was performed fol-
lowing the addition of 49 μl of trichloracetic acid (30 %). 
Following hydrolysis process of N-formyl-kynurenine to 
kynurenine has been completed, Then the measurement 
of the enzyme activity was performed by mixing of 100 μl 
of reaction mixture together with 100 μl Ehrlich reagent 
(0.4  % p-methyaminobenzaldehyde/acetic acid) using a 
Microplate reader (ImmunoReader NJ-2000 Nunc, Wies-
baden, Germany). The absorbance was at 490 nm.
Immunoblot
Protein analysis was performed using standard immune 
blotting. The following antibodies were used at the 
indicated dilution: anti-Noxa (SC-2697) 1:1000; anti-
cytochrome (#4212), 1:1000; anti-caspase 3 (#7190), 
1:1000; anti-caspase 9 (#9501), 1:1000; anti-PARP 
(#9542), 1:500 (each Cell Signaling Technology Inc., Dan-
vers, MA, USA); anti-IDO antibody 1:500 (BioGenes, 
Berlin, Germany); anti-ASK1 (Sc-7931), 1:500; anti-p-
ASK1 (Sc-109911), 1:1000; anti-JNK (Sc-474), 1:1000; 
anti-p-JNK (SC-6254), 1:1000; anti-p38 (Sc-535), 1:1000; 
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anti-p-p38 (Sc-7973), 1:1000; anti-Actin (Sc-1615), 
1:5.000; anti-Tom20 (Sc-11415), 1:100; anti-Bap31 (Sc-
18579), 1:1000; anti-HO-1 (sc-10789), 1:1000; anti-p-
JAK1 (sc-16773), 1:1000, anti-IRE1α (Sc-20790), 1:500; 
anti-PERK (SC-9477), 1:1000; (Santa Cruz Biotechnol-
ogy Inc., Santa Cruz, CA, USA); anti-IκBα (Sc-7182), 
1:1000; anti-p-IκBα (AF4809, R&D system), 1:1000; anti-
JAK1 antibody (ab47435), 1:1000; anti-IRF1 antibody 
(ab55330), 1:1000 (each ABCAM).
Extraction of nuclear proteins
The extraction of the nuclear proteins from IFNγ-treated 
CLS-354 and RPMI 2650, and control cells was per-
formed as described previously [30]. Briefly, following the 
washing twice with ice-cold PBS buffer the cells were har-
vested from culture dish with 500 μl of buffer A (20 mM 
Hepes, pH 7.9; 10 mM NaCl, 0.2 mM EDTA; and 2 mM 
DTT) supplemented with a recommended concentra-
tion of protease inhibitors. After the incubation on ice for 
10 min the cells were centrifuged at 14,000×g for 3 min 
to sediment the cell nuclei. The supernatant the contains 
the cytoplasmic protein was kept at −20  °C for further 
analysis, while the nuclear pellet was used to extract the 
nuclear proteins. Accordingly the collected nuclear pel-
let was resuspended in 50 µl of buffer C (20 mM Hepes, 
pH 7.9; 420 mM NaCl, 0.2 mM EDTA; 2 mM DTT; 1 mM 
Na3VO4, 25 % glycerol) with appropriate amount of pro-
tease inhibitors. After the incubation on ice for 20  min 
the nuclear proteins were purified by the at 14,000×g for 
3 min. The supernatant that contains the nuclear protein 
was collected for direct analysis or stored at −80 °C until 
use.
Electrophoretic mobility shift assay
The DNA-binding activity of the transcription factors 
have been analysed as described previously [30]. Briefly, 
the double stranded synthetic oligonucleotides that 
represent the specific binding sites of the correspond-
ing transcription factors including, AP-1, ATF-2, p53, 
NF-κB, STAT1, IRF-1 each purchased from Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, USA. The double 
stranded DNA consensus sequence consensus were end-
labelled with [γ-32P] ATP (Hartmann Analytika, Munich, 
Germany) using T4 polynucleotide kinase (Genecraft, 
Lüdinghausen, Germany). While the measurement of the 
DNA-binding activity of each transcription factors was 
performed by the incubation of 4 µg of nuclear extracts 
with a labelled probe of the transcription factors of inter-
est in a total reaction volume of 30 µl containing EMSA 
binding buffer (10 mM Tris, pH 7.5; 50 mM NaCl, 1 mM 
EDTA; 1  mM MgCl2; 0.5  mM DTT and 4  % glycerol). 
After the incubation for 30 min at room temperature the 
DNA-binding activity of the transcription factors were 
analyzed by electrophoresis for 3 h at 100 V in 0.5× Tris–
borate-EDTA running buffer at room temperature. The 
dried gel was visualized by exposure to high performance 
autoradiography film.
Flow cytometry analysis of apoptosis using annexin V/PI
The analysis of apoptosis of IFNγ-treated and control 
cells was performed following the staining with 5  µl of 
annexin V-FITC (Vybrant; Invitrogen, Karlsruhe, Ger-
many) and 5 µl propodeum iodide (100 µg/ml). After the 
incubation for 15  min at room temperature the num-
ber of apoptotic cells were assessed by flow cytometry 
described previously [28].
Measurement of mitochondrial membrane potential 
(ΔΨm) using JC‑1
IFNγ- treated CLS-354 and RPMI 2650 cells were stained 
with 10  μM JC-1 (10  mM; Biotrend, Cologne, Ger-
many) for 30 min at room temperature in the dark. The 
intensities of green (520–530  nm) and red fluorescence 
(>550  nm) of 50,000 individual cells were analyzed by 
flow cytometry as described previously [28].
Measurement of reactive of oxygen species
The measurement of reactive oxygen species (ROS) in 
IFNγ- treated and control cells was performed by flow 
cytometry following the staining with DHR 123 (Sigma) 
as described [30].
Immunofluorescence staining
IFNγ- treated and control cells were subjected to immu-
nofluorescence staining as described [31]. Primary 
antibodies, anti-Noxa (SC-2697), 1:200; anti-Tom20 (Sc-
11415), 1:200; anti-Bap31 (Sc-18579), 1:200 (each Santa 
Cruz Biotechnology Inc., CA, USA) were incubated 
treated and control cells for 2  h at room temperature. 
After three successive washing with PBS, the cells were 
incubated with Alexa Flour labelled secondary antibod-
ies for 2 h at room temperature protected from light. To 
remove nonspecific binding of the secondary antibodies, 
the cells were washed three times with PBS, and subse-
quently mounted using DAKO mounting medium. Pho-
tomicrographs were taken on a fluorescence microscope 
(Leica, Wetzlar, Germany).
Preparation of mitochondrial and endoplasmic reticulum 
fractions
The preparation of mitochondrial and endoplasmic 
reticulum (ER) fractions was performed as described 
previously [30]. Briefly, IFNγ- treated and control cells 
(CLS-354 and RPMI 2650) were scraped off with 5  ml 
of phosphate-buffered saline and collected by the cen-
trifugation at 600×g for 5  min. After three washing in 
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PBS buffer the cells have been washed, resuspended and 
homogenized in PBS buffer. After the centrifugation at 
600×g for 5  min, the cell the supernatant was layered 
over a discontinuous gradient of 40 and 60  % sucrose 
in HE buffer (3 and 1  ml, respectively). Following the 
centrifugation at 100,000×g for 3 h, aliquots of the cor-
responding of the mitochondrial or ER fractions were 
precipitated with 10  % trichloroacetic acid (TCA) were 
directly subjected to western blot analysis or stored at 
−80 °C until use.
Statistical analysis
The statistical analysis was performed by consider-
ing the average of a at least three independent experi-
ments (n  =  3) and average values are expressed as the 
mean ± SD. The data analysis was performed using Stu-
dent’s t test method.
Results
Effect of IFNγ on the viability of HNSCC cells
Initially, we performed a time-course experiment to 
assess the cytotoxicity of IFNγ by treating HNSCC cells 
with IFNγ for time periods up to 72 h. We first assessed 
IFNγ-induced effects on HNSCC cell viability using a 
MTT assay. Both CLS-354 and RPMI 2650 cells were 
cultured for 24 h before the exposure to IFNγ (1000 U/
ml). MTT assay (Fig.  1a) indicated that IFNγ treatment 
resulted in an inhibition of proliferation of both CLS-
354 and RPMI 2650 cells. This inhibition was apparent 
at 12 h after treatment and reached a maximum by 72 h 
in both cell lines. Next, we investigated whether treat-
ment with IFNγ induced apoptosis. Following treatment 
with IFNγ for 48  h, the cells were analyzed for apopto-
sis by flow cytometry using annexin V/PI staining. As 
expected, IFNγ treatment induced apoptosis in both cell 
lines (Fig.  1b), suggesting the involvement of an apop-
totic mechanism in the modulation of IFNγ-induced 
death of HNSCC cells. Next, we confirmed whether 
IFNγ-induced apoptosis is associated with the loss of 
mitochondrial membrane potential (Δψm). Accord-
ingly, we analysed Δψm of control and treated cells by 
flow cytometry following staining with JC-1. Flow cyto-
metric analyses (Fig.  1c) demonstrated the loss of Δψm 
markedly in response to the exposure HNSCC cells to 
IFNγ, suggesting an important role for mitochondrial 
dysregulation in the modulation of IFNγ-induced apop-
tosis. We hypothesized that IFNγ-induced loss of Δψm is 
associated with the accumulation of reactive oxygen spe-
cies (ROS). The cells were subjected to flow cytometry 
analysis ROS using dihydrorhodamine 123 (DHR123) 
after the exposure to IFNγ for the recommended time 
periods. Flow cytometry data (Fig. 1d) revealed the eleva-
tion of ROS accumulation in response to the treatment of 
HNSCC cells with IFNγ, which suggests a central role for 
IFNγ-induced ROS accumulation in the modulation of 
IFNγ-induced apoptosis of HNSCC cells. Next, we ana-
lysed the expression of molecular markers of apoptosis, 
including cytochrome c, caspase-9, caspase-3, and PARP 
in HNSCC cells. In addition, we analysed the expres-
sion of the pro-apoptotic protein Noxa, the expression 
of which is mostly associated with mitochondrial dam-
age [31]. The analysis of the total protein of treated and 
control cells by Western blot (Fig. 1e) demonstrated the 
induction of cytochrome c release, as well as the cleavage 
of caspases-9, and -3, and PARP. The pro-apoptotic pro-
tein Noxa was also expressed by HNSCC after exposure 
to IFNγ.
IFNγ‑induced expression of IDO is associated with the 
suppression of heme oxygenase‑1
As widely reported, the mutual crosstalk between heme 
oxygenase-1 (HO-1) and IDO can influence cellular fac-
tors that are thought to be associated with cell death 
and proliferation [32]. We investigated whether IFNγ-
induced IDO expression influences basal heme oxyge-
nase-1(HO-1) expression. The cells were treated with of 
IFNγ for 48 h the cells and total cell lysates were used for 
the protein expression analysis of IDO, interferon regula-
tory factor-1 (IRF-1), and HO-1 by western blot. In addi-
tion, we analysed the expression and phosphorylation of 
the Janus kinase 1 (Jak1) as well as IDO activity. Western 
blot analyses (Fig.  2a) demonstrated the ability of IFNγ 
to induce expression of both IDO and IRF-1 as well as 
both expression and phosphorylation of Jak1, while sup-
pressing HO-1 expression. In addition, we assessed the 
activity of the transcription factors STAT1, NF-κB, and 
IRF-1, which are thought to be responsible for the induc-
tion of IDO expression in response to the treatment of 
HNSCC cells by IFNγ. The analysis of the transcription 
factors were performed by electrophoretic mobility shift 
assay (EMSA) using nuclear extracts prepared from CLS-
354 and RPMI 2650 cells before and after the exposure 
to IFNγ. EMSA (Fig.  2b, c) demonstrated the activation 
of the transcription factors STAT1, NF-κB, and IRF-1 
in response to the treatment with IFNγ, suggesting an 
important role for these transcription factors in the mod-
ulation of IFNγ- induced IDO expression and its conse-
quences in HNSCC cells.
The exposure of HNSCC cells to IFNγ is associated with the 
activation of ASK1‑dependent pathways
Accumulation of ROS is associated with the activation of 
apoptosis signalling regulating kinase 1 (ASK1) and its 
downstream signalling pathways such as c-Jun-N-termi-
nal kinase (JNK), p38 and NF-κB [28, 33]. To analyse key 
components of ASK1-dependent pathways, CLS-354 and 
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RPMI 2650 cells were treated with IFNγ for 48  h, then 
total cell lysates were prepared for western blot analyses 
of ASK1, JNK, p38, and IκBα. The exposure of CLS-354 
and RPMI 2650 cells to IFNγ induced the phosphoryla-
tion of ASK1, JNK, p38 and IκBα proteins (Fig. 3a). More 
importantly, the phosphorylation of IκBα was associ-
ated with its subsequent degradation, while there was 
no alteration in the basal expression level of ASK1, JNK, 
or p38 proteins (Fig.  3a). Also, we investigated whether 
IFNγ-induced activation of ASK1-JNK, ASK1-p38 or 
NF-κB pathways is associated with the enhancement of 
the DNA-binding activity of the transcription factors 
AP-1, p53, ATF-2 and NF-κB. The analysis of the DNA-
binding activities of the transcription factors of interest 
by EMSA using the nuclear extracts of IFNγ-treated cells 
demonstrated the activation of the transcription factors 
AP-1 (Fig. 3b), ATF-2 (Fig. 3c), p53 (Fig. 3d) and NF-κB 
(Fig. 3e), suggesting an important role for ASK1-depend-
ent pathways in the modulation of IFNγ-induced activa-
tion of the transcription factors AP-1, ATF-2, p53 and 
NF-κB.
IFNγ‑induced accumulation of ROS is attributed to the 
suppression of HO‑1 by IDO
In order to determine if IFNγ-induced accumula-
tion of ROS is the consequence of HO-1/IDO cross-
regulation, we investigated if the suppression of IDO 
expression using siRNA might influence IFNγ-induced 
Fig. 1 a Time course experiment demonstrates cell growth inhibition of HNSCC cell lines CLS-354 and RPMI 2650. Relative cell number (%) assessed 
by MTT assay following the exposure of cells to IFNγ (1000 U/ml) for regulated time intervals up to 72 h. The values are expressed as the mean ± SD 
of three independent experiments performed in duplicate. The Student’s t test was used for analysis. b Flow cytometry analysis of the induced 
apoptosis of CLS-354 and RPMI 2650 cells using annexin V/PI staining following the exposure to IFNγ for 48 h. c Flow cytometry analysis of the 
mitochondrial membrane potential (Δψm) in CLS-354 and RPMI 2650 cells using JC-1 staining following the exposure to IFNγ for 48 h. d Assess-
ment of ROS level in CLS-354 and RPMI 2650 cells following the exposure to IFNγ for 48 h. ROS generation was measured by flow cytometry using 
dihydrorhodamine (DHR 123). e Western blot analysis of the pro-apoptotic protein Noxa, cytochrome c, cleavage of caspase-9, caspase-3 and PARP 
following the exposure of CLS-354 and RPMI 2650 cells to IFNγ for 48 h. Actin was used as internal control for loading and transfer. Data are repre-
sentative of three dependent experiments performed separately
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accumulation of ROS and subsequently alter the expres-
sion level of HO-1. The role of HO-1 in the modulation 
of redox imbalance has been reported in several studies 
[34, 35]. Also, the crosstalk-regulation between HO-1/
IDO is essential for ROS-induced effects. After treat-
ment for 48  h, treated and control cells were harvested 
for the preparation of total cell lysates for western blot 
analysis of IDO, interferon regulatory factor-1 (IRF-1) 
and HO-1 proteins, as well as for the assessment of ROS 
accumulation by flow cytometry. When cells were trans-
fected with an IDO-specific siRNA, the IFNγ-induced 
expression of IDO was knocked down when compared 
to the expression level of IDO in treated and control 
cells (Fig.  4a). Interestingly, IFNγ-induced expression of 
IDO expression correlated with the suppression of HO-1 
when compared to control cells (Fig.  4a), suggesting an 
essential role for IFNγ-induced IDO in the suppression 
of HO-1. To test this, we examined the inhibitory effect 
of the 1-methyltryptophan (1-MT), the inhibitor of IDO 
enzyme, on IFNγ-induced IDO activity and its affect on 
HO-1. Following the pre-treatment with 1-MT, CLS-
354 and RPMI 2650 cells were challenged with IFNγ for 
48 h, then the IDO activity was determined in the total 
cell lysates by ELISA. This assay demonstrated the sup-
pression of IFNγ- induced IDO activity in both HNSCC 
cells by 1-MT (Fig.  4b). Also, the inhibition of IFNγ-
induced IDO activity is involved in the suppression of 
HO-1 (Fig.  4c). To determine whether the inhibition of 
IDO-induced suppression of HO-1 is essential for mod-
ulation of IFNγ-induced ROS accumulation in HNSCC 
cells, prior to the exposure to IFNγ the cells were either 
transfected with IDO specific siRNA or pre-treated with 
1-MT. The analysis of ROS accumulation by flow cytom-
etry using DHR123 in RPMI 2650 and CLS-354 cells 
(Fig.  4d) demonstrated the reduction of IFNγ-induced 
ROS accumulation by the suppression of IDO expression 
or activation by its siRNA or 1-MT, respectively, when 
compared to control cells. These findings indicate that 
Fig. 2 a Western blot analysis of JAK1, IRF-1, IDO and HO-1 in CLS-354 and RPMI 2650 cells following the exposure to IFNγ for 48 h. Actin was used 
as an internal control for loading and transfer. EMSA demonstrates the enhancement of the DNA-binding activity of the transcription factors IRF-1 
(b) and STAT1 (c) following the exposure of CLS-354 and RPMI 2650 cells to IFNγ for 48 h. Data are representative of three independent experiments 
with similar results
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the increased accumulation of ROS is the consequence of 
IFNγ-induced IDO leading to the suppression of HO-1.
The pre‑treatment of HNSCC cells with NAC blocks 
IFNγ‑induced activation of ASK1‑JNK, ASK‑p38 and NF‑κB 
pathways
In order to further analyze the role of ROS in IFNγ-
induced activation of ASK1 and its downstream path-
ways, CLS-354 and RPMI 2650 cells were pre-treated 
with N-acetyl-l-cysteine (NAC) before exposure to IFNγ 
for 48  h. Subsequently, total cell lysates and nuclear 
extracts were prepared to perform western blot analyses 
and EMSA assays, respectively. The suppression of ROS 
accumulation by NAC inhibited IFNγ-induced phospho-
rylation of ASK1, JNK, p38, and of IκBα together with the 
subsequent degradation of IκBα (Fig.  5a), suggesting an 
important role for IFNγ-induced ROS accumulation in 
the activation of ASK1-JNK/- p38, and NF-κB pathways. 
In addition, the DNA-binding activity of the transcrip-
tion factors AP-1, p53, ATF-2 and NF-κB were analyzed 
by EMSA. The inhibition of IFNγ-induced activation of 
the transcription factors AP-1 (Fig. 5b) and p53 (Fig. 5c) 
by the inhibitor of JNK pathway (SP600125) suggested 
an important role for JNK in their regulation. Simi-
lar results have been demonstrated in RPMI 2650 (data 
not shown). The inhibitor of p38 (SB203580) was found 
to inhibit IFNγ-induced activation of the transcription 
factor ATF-2 in CLS-354 cells (Fig.  5d), suggesting an 
important role for p38 in the regulation of ATF-2 acti-
vation. A similar effect was noted in RPMI 2650 cells in 
response to the pre-treatment with inhibitor of p38 (data 
not shown). Also, the inhibition of NF-κB pathway by its 
specific inhibitor (Bay11-7082) inhibited IFNγ-induced 
DNA-binding activity of NF-κB in CLS-354 (Fig. 5e). The 
same effects were noted in RPMI 2650 (data not shown).
IFNγ‑induced apoptosis of HNSCC cells is the consequence 
of Noxa‑mediated mitochondrial dysregulation
To show whether IFNγ-induced apoptosis is the conse-
quence of the subcellular localization of Noxa protein to 
Fig. 3 a Western blot analysis of ASK1, JNK, p38 and IκBα in CLS-354 and RPMI 2650 cells following the exposure to IFNγ for 48 h. Actin was used 
as an internal control for loading and transfer. EMSA demonstrates the enhancement of DNA-binding activity of the transcription factors AP-1 (b), 
ATF-2 (c), p53 (d) and NF-κB (e) following the exposure of CLS-354 and RPMI 2650 cells to IFNγ for 48 h. Data are representative of three independ-
ent experiments with similar results
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the mitochondria and/or ER, both CLS-354 and RPMI 
2650 cells were treated with IFNγ for the indicated time 
periods before analysis of the subcellular localization of 
Noxa protein using immunofluorescence and western 
blot. Following the treatment with IFNγ for 48 h, the cells 
were fixed and subsequently subjected to the staining 
with antibodies against Noxa, the mitochondrial marker 
Tom20, and the ER marker Bap31. Immunofluorescence 
staining confirmed the localization of Noxa protein to 
both mitochondria and ER in CLS-354 (Fig.  6a) and 
RPMI 2650 (Fig. 6b) cells. In addition to immunofluores-
cence staining we prepared mitochondrial and ER subcel-
lular fractions for western blot analyses for confirmation 
of the immunofluorescence data. Immunoblot analysis 
of both mitochondrial and ER fractions prepared from 
treated and control cells revealed the presence of Noxa 
protein only the mitochondrial and ER fractions of IFNγ 
in treated cells (Fig. 6c). Tom20 and Bap31 proteins were 
used as marker for the purity of mitochondrial and ER 
fractions, respectively. In conclusion, these data suggest 
that IFNγ-induced IDO is essential for the modulation 
of mitochondrial dyseregulation as well as ER stress via 
a mechanism mediated by the subcellular localization of 
Noxa protein to both mitochondria and ER (Fig. 6c). To 
further characterize the ER dysfunction, we analysed ER 
stress associated proteins such as protein kinase RNA-
like endoplasmic reticulum kinase (PERK), inositol-
requiring-1α (IRE1α), calpain, and caspase-4. The cell 
Fig. 4 a Western blot analysis of IDO and HO-1 proteins following the knockdown of IDO expression by its specific siRNA before and after the 
exposure of CLS-354 and RPMI 2650 cells to IFNγ for 48 h. Actin was used as internal control for loading and transfer. b Spectrofluorometric analysis 
shows the ability of 1-methyl-d-tryptophan (1-MT) to block IFNγ-induced IDO activity in both CLS-354 and RPMI 2650 cells. Cells were grown with 
medium alone or medium containing IFNγ in the absence or presence of 1-MT for 48 h. The supernatant was collected, and residual tryptophan 
was converted to norharman. Norharman levels were measured by a spectrofluorometer using 360 and 640 nm as excitation and emission wave-
lengths, respectively. The values are expressed as the mean ± SD of three independent experiments performed in duplicate. The student’s t-test 
was used for analysis. c Western blot analysis demonstrates the inhibition of INFγ-induced activation of IDO results in the rescue of IFNγ-induced 
suppression of HO-1 protein. Actin was used as internal control for loading and transfer. d Flow cytometry analysis of IFNγ-induced accumulation 
of the reactive oxygen species (ROS) using DHR 123 in RPMI 2650 and CLS-354 cells following the knockdown of IDO by its specific siRNA or the 
inhibition of IDO enzyme activity by 1-MT. ROS generation was measured by flow cytometry using dihydrorhodamine (DHR 123). The values are 
expressed as the mean ± SD of three independent experiments performed in duplicate. The Student’s t test was used for analysis
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lines were treated with the recommended concentration 
of IFNγ for 48 h and the total cell lysates of treated- and 
control cells were subjected to western blot analysis. 
Although no changes was noted on the basal expression 
of either PERK or IRE1α, the exposure of the cells to IFNγ 
is able to enhance the phosphorylation of PERK as well 
as IRE1α (Fig. 6d) suggesting the induction of ER stress 
as consequence of Noxa localization to the ER. Next, 
we set out to address the pathways which are respon-
sible for the regulation of IFNγ-induced Noxa expres-
sion. Accordingly, we analysed the effect of ASK1, JNK, 
p38, ROS and NF-κB inhibitors on IFNγ-induced Noxa 
expression. The pre-treatment of both CLS-354 (Fig. 6e) 
and RPMI 2650 (Fig. 6f ) cells with the inhibitors of ASK1, 
JNK, ROS and NF-κB, but not with those of p38, are able 
to block IFNγ-induced expression of Noxa, suggesting 
an essential role for ASK1-JNK and ASK1- NF-κB path-
ways, but not ASK1-p38 pathway in the regulation of 
IFNγ-induced Noxa expression. Moreover, we examined 
the effect of the inhibition of ASK1-JNK, ASK1-p38 and 
ASK1-NF-κB pathways on IFNγ-induced cell death. The 
CLS-354 and RPMI 2650 cells were pre-treated with the 
inhibitors of ASK1, JNK, p38, ROS and NF-κB before the 
exposure to IFNγ for 48 h, then the cell viability was ana-
lysed by MTT assay (Fig. 6g, h), the inhibition of IFNγ-
induced ROS accumulation or activation of ASK1, JNK, 
and NF-κB pathways, but not the inhibition of p38 path-
way can block IFNγ-induced death of CLS-354 and RPMI 
2650 cells, suggesting an important role for the pathways 
ASK1-JNK, and NF-κB in the regulation of IFNγ-induced 
apoptosis of CLS-354 and RPMI 2650 cells via Noxa-
dependent mitochondrial damage.
Fig. 5 a Western blot analysis demonstrates the inhibition of IFNγ-induced phosphorylation of ASK1, JNK and p38 as well as the IFNγ-induced 
phosphorylation and degradation of IκBα in response to the pre-treatment of CLS-354 and RPMI cells with the scavenger of ROS. Actin was used as 
internal control for loading and transfer. EMSA analysis demonstrates the inhibition of IFNγ-induced DNA-binding activity of the transcription fac-
tors AP-1 (b) and p53 (c) in response to the pre-treatment of CLS-354 cells by the inhibitor of JNK pathway (SP60015). Whereas, the pre-treatment of 
the same cells with the inhibitors of p38 (SB203580) or the inhibitors of NF-κB pathway (Bay11-7082) was found to block IFNγ-induced DNA-binding 
activity of ATF-2 (d) and NF-κB (e), respectively. Data are representative of three independent experiments performed separately
Page 10 of 14El Jamal et al. Cell Div  (2016) 11:11 
Discussion
The present study provides a new insight into the mecha-
nistic role of IFNγ-induced apoptosis of HNSCC cells 
and describes the possible role of IDO in the modula-
tion of IFNγ-induced apoptosis during the course of 
immune therapy. The treatment of the HNSCC with 
IFNγ at a concentration of 1000  IU/ml is based on the 
determined IC50 as well as on the recommended dose by 
Yonekura et al. as described [36]. IFNγ-induced apoptosis 
of HNSCC cells is a result of the IDO-induced suppres-
sion of HO-1, which leads to the increased accumulation 
of ROS that, in turn, triggers the induction of oxida-
tive stress-associated pathways. These pathways include 
ASK1-JNK, ASK-p38 and ASK1-IKK/NF-κB that are 
essential for the induction of the pro-apoptotic protein 
Noxa. The subcellular localization of Noxa protein trig-
gers mitochondrial dysregulation, an essential step for 
the initiation of apoptosis. Accordingly, the present study 
demonstrated the involvement of ASK1-JNK-p53/AP-1 
and ASK1-IKK-NF-κB pathways in the modulation of 
IFNγ-induced Noxa expression. The activation of these 
signalling pathways is expected to be the consequence 
Fig. 6 a Subcellular localization of Noxa protein to both mitochondria and endoplasmic reticulum (ER). Immune fluorescence: CLS-354 and RPMI 
2650 cells were treated with IFNγ for 48 h before the staining with anti- Noxa, Tom20 (mitochondrial marker) and Bap31 (ER marker). The subcellular 
localization of Noxa (green) to mitochondria (red) and the overlay of Noxa with Tom20 staining demonstrates the localization of Noxa to mitochon-
dria (yellow), when compared to control cells. b The subcellular localization of Noxa (green) to ER (blue) and the overlay of Noxa with Bap31 staining 
demonstrates the localization of Noxa to ER (turquoise), when compared to control cells. c Western blot analysis using mitochondrial fraction (Mit. 
fraction) and ER fraction from both CLS-354 and RPMI 2650 cells following the treatment with IFNγ for the indicated time periods. The detection 
of Noxa in mitochondrial and ER fractions of CLS-354 and RPMI 2650 cells after the exposure to IFNγ confirm the localization of Noxa protein to 
both mitochondria and ER. The purity of both mitochondrial and ER fractions was verified by the detection of the mitochondrial protein Tom20 in 
the mitochondrial fraction and the detection of Bap31 in ER fraction. d Western blot analysis demonstrates the phosphorylation of both PERK and 
IRE1α, calpain degradation, and cleavage of caspase-4 in response to the treatment of HNSCC cells with IFNγ. e Western blot analysis demonstrates 
the inhibition of IFNγ-induced expression of Noxa in RPMI 2650 in response to the pre-treatment with the inhibitors of the ASK1 (thioredoxin), 
JNK (SP600125), ROS (NAC) and NF-κB (Bay11-7082), but not with those of p38 (SB208035). f Western blot analysis demonstrates the inhibition of 
IFNγ-induced expression of Noxa in CLS-354 cells in response to the pre-treatment with the inhibitors of the ASK1 (thioredoxin), JNK (SP600125), 
ROS (NAC) and NF-κB (Bay11-7082), but not with those of p38 (SB208035). Actin was used as internal control for loading and transfer. Data are 
representative of three independent experiments. g MTT demonstrates the inhibition of IFNγ-induced death of RPMI 2650 cells in response the pre-
treatment with the inhibitors of the ASK1 (thioredoxin), JNK (SP600125), ROS (NAC) and NF-κB (Bay11-7082), but not with those of p38 (SB208035). h 
MTT demonstrates the inhibition of IFNγ-induced death of CLS-354 cells in response to the pre-treatment with the inhibitors of the ASK1 (thiore-
doxin), JNK (SP600125), ROS (NAC) and NF-κB (Bay11-7082), but not with those of p38 (SB208035). The values are expressed as the mean ± SD of 
three independent experiments performed in duplicate. The Student’s t test was used for analysis
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of IDO-induced suppression of HO-1 leading to ROS. 
Although the subcellular localization of Noxa protein 
to both ER and mitochondria has been observed, Noxa-
induced mitochondrial damage seems to be essential for 
IFNγ-induced apoptosis of HNSCC cells. The localization 
of Noxa protein to mitochondria is associated with the 
loss of ΔΨm and the subsequent release of cytochrome c, 
and, cleavage of caspases-9, 3 and PARP, whereas IFNγ-
induced Noxa to ER seems to be associated with the 
induction of ER stress, as evidenced by the phosphoryla-
tion of PERK and IRE1α.
IFNγ exerts its pleiotropic effects on normal and malig-
nant cells via the interaction with a specific receptor that 
is commonly expressed on the surface of most eukary-
otic cells [37–39]. The role of IFNγ in the regulation of 
IDO has been reported in several studies [40, 41]. IFNγ- 
induced IDO is mediated by JAK-STAT pathway-depend-
ent mechanism(s) [42]. IDO belongs to a pattern of gene 
Fig. 7 Proposed model for IFNγ-induced apoptosis of HNSCC cells. The activation of IFNγ receptor of HNSCC cells with IFNγ results in the activation 
of JAK-STAT pathway that subsequently enhances the DNA binding activity of the transcription factor interferon regulatory factor-1 (IRF-1) that is 
essential for the induction IDO expression. The increased level of IDO results in the suppression of the anti-oxidant protein heme oxygenase-1 (HO-
1) that, in turn, leads to the accumulation of reactive oxygen species (ROS). The increased accumulation of ROS mediates oxidative stress-associated 
pathways such as apoptosis signal-regulating kinase 1(ASK1)/c-Jun-N-terminal kinase (JNK)-AP-1/p53, IKK-NF-κB, and p38-ATF-2. The formation of a 
transcriptional complex from the transcription factors NF-κB, AP-1 and p53 results in the transcriptional activation of the promoter of Noxa protein. 
The localization of Noxa protein to mitochondria results in the loss of mitochondrial membrane potential (Δψm) that is characterized by the release 
of cytochrome c (Cyt.C) into the cytoplasm where it initiates apoptosis by formation of apoptosome complex leading to the cleavage of caspase-9, 
caspase-3 and PARP. Whereas the localization of Noxa to endoplasmic reticulum (ER) results in ER-stress that is associated with the activation of the 
protein kinase RNA-like endoplasmic reticulum kinase (PERK) and inositol-requiring-1α (IRE1α) pathways as well as cleavage of caspase-4 that, in 
turn, mediates the cleavage of caspase-3
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transcripts such as JAK2, IRF-1 and STAT1α [42]. Thus, 
the activation of the JAK-STAT pathway is associated 
mainly with the increased phosphorylation of JAK1 and 
the induction of both expression and DNA-binding activ-
ity of IRF-1.
The rescue of IFNγ-induced apoptosis by IDO inhibi-
tion provides evidence for the involvement of IDO in the 
modulation of IFNγ-induced apoptosis. Although the 
role of IDO as apoptotic mediator has been described 
previously [18, 43], we describe for the first time a central 
role for IDO in the modulation of IFNγ-induced apopto-
sis of HNSCC cells. Apoptosis of HNSCC cells by IFNγ is 
regulated by IDO-mediated suppression of HO-1 leading 
to the accumulation of ROS. As a consequence, the accu-
mulation of ROS triggers the activation of ASK1-JNK 
and ASK1-NF-κB pathways [18, 33]. The role of HO-1 in 
the inhibition of apoptosis via mechanism mediated by 
the suppression of oxidative stress-associated pathways 
has been reported in several studies [44–46]. In accord-
ance, we found that the induction of IDO expression or 
activation results in the suppression of HO-1 protein 
that, in turn leads to ROS accumulation. The involve-
ment of IDO in the modulation of IFNγ-induced apop-
tosis is supported by the findings that demonstrate the 
rescue of IFNγ-induced suppression of HO-1 along with 
the inhibition of IFNγ-induced apoptosis in response to 
the knockdown of IDO expression or inhibition of IDO 
activity.
The role of mitochondrial dysregulation associated 
pathways in the modulation of IFNγ-induced apoptosis 
has been reported in several studies [47–49]. Similarly, 
we found that IFNγ-induced mitochondrial damage is the 
consequence of the activation of ASK1-JNK, ASK1-JNK 
and NF-κB pathways leading to the activation of the tran-
scription factors AP-1, p53 and NF-κB. These transcrip-
tion factors are thought to form a transcription complex 
that is essential for the promoter activation of Noxa gene. 
Since the induction of apoptosis of HNSCC cells by IFNγ 
is associated with Noxa-induced loss of Δψm.
Conclusion
Our data provide insight into the possible mechanisms 
of the anti-tumor activity of IFNγ during the course of 
immune therapy and demonstrate for the first time an 
essential role for IDO as a mediator of IFNγ-induced 
apoptosis of HNSCC cells. IFNγ-induced apoptosis of 
HNSCC cells is regulated via a mechanism mediated by 
IDO-induced suppression of the antioxidant protein HO-1 
that, in turn, leads to an increase of ROS accumulation. 
The increased accumulation of ROS is essential for the 
activation of oxidative stress-dependent pathways includ-
ing ASK1-JNK, ASK1-JNK and NF-κB axis. Thus, based 
on our findings we proposed a model for IFNγ-induced 
apoptosis of HNSCC cells (Fig. 6). This model outlines the 
possible mechanism(s) that are implicated in the regula-
tion of HNSCC response to immunotherapy (Fig. 7).
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